How do you pay?

How to pay the least

Ask for the cash price

Vocabria

We didn’t find one.

What to do

  1. Ask your pharmacy for Vocabria’s cash price, and one or two other pharmacies too.

Compare every option

Brand name

Vocabria, the original

Cash priceAsk the pharmacy
Ways to save on Vocabria

With a free discount coupon

Optum Perks, Optum’s free discount coupon, lists these prices for Vocabria without insurance. Show the coupon from its page at the pharmacy; it can’t be used with insurance.

From Optum Perks, read November 17, 2026, with no location set. Its page opens on this dose; other doses and pharmacies near you are priced there too. With insurance, check your co-pay first: it may be lower.

Authorized generic

There isn’t one.

Not soldThere isn’t one

Regular generic

We didn’t find one.

Not soldNone found

What it’s used for

What the FDA label says

HIV-1 Treatment: VOCABRIA is an HIV-1 integrase strand transfer inhibitor (INSTI) indicated in combination with EDURANT (rilpivirine) for short-term treatment of HIV-1 infection in adults and adolescents 12 years of age and older and weighing at least 35 kg who are virologically suppressed (HIV-1 RNA <50 copies/mL) on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.

HIV-1 Pre-Exposure Prophylaxis: VOCABRIA is indicated for short-term pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in adults and adolescents weighing at least 35 kg who are at risk for HIV-1 acquisition. Individuals must have a negative HIV-1 test prior to initiating VOCABRIA for HIV-1 PrEP.

VOCABRIA may be used as:

  • oral lead-in to assess the tolerability of cabotegravir prior to administration of CABENUVA (cabotegravir extended-release injectable suspension; rilpivirine extended-release injectable suspension) for HIV-1 treatment or APRETUDE (cabotegravir extended-release injectable suspension) for HIV-1 PrEP.
  • oral therapy for patients who will miss planned injection dosing with CABENUVA for HIV-1 treatment or APRETUDE for HIV-1 PrEP.

Source: the FDA label for Vocabria (ViiV Healthcare Company), April 11, 2025. Full label on DailyMed 

Good to know

  • We didn’t find a savings card from Vocabria’s maker.
  • Don’t stop or change a medicine without talking to your pharmacist or prescriber.